Cohance Lifesciences fundamental analysis
COHANCE
520
1.70 (0.33%)Last updated on 3 Jan, 2026 | 13:09 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Cohance Lifesciences Fundamentals
P/E Ratio
79.82
P/B Ratio
5.22
Div. Yield
0
Sector P/E
72.47
Sector P/B
1.02
Sec. Div. Yield
0.56
Cohance Lifesciences Fundamentals is currently trading with a P/E Ratio of 79.82, compared to the sector average of 72.47. Its P/B Ratio stands at 5.22, while the sector’s is 1.02. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Cohance Lifesciences Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Cohance Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
